Paraglide HF

Study Information

Status: Active, Not Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

San Francisco

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

A Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Active Controlled Study to Evaluate the Effect of Sacubitril/Valsartan (LCZ696) Versus Valsartan on Changes in NT-proBNP and Outcomes, Safety, and Tolerability in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization and Initiated In-hospital or Within 30 Days Post-discharge (PARAGLIDE-HF)

Location: CPMC (San Francisco)

Please contact: Milena Ferreira ferreiml@sutterhealth.org about study Paraglide HF

Principal Investigator

Ranjan Ray, MD

Co-Investigator(s)

Michael Pham, MD, MPH, Yu Xie, MD, Jared Herr, MD

Related Studies

Interpretable Deep Learning Model for Longitudinal Electronic Health Record and Applications to Heart Failure Prediction

Develop advanced deep learning model to predict early onset heart failure using EHRs, including structured and unstructured data.

Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator

Heart Failure Prevention "2 of 3 Study".

Primary prevention of heart failure among older adults who have no prior heart failure, myocardial infarction, nor advanced renal impairment

Investigators: Francisco Prieto, MD, Andrew Hudnut, MD, Craig Ruggles, M.D.

Interagency Registry for Mechanically Assisted Circulatory Support

Investigator: Robert Kincade, M.D., FACS